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West Nile virus (WNV), Japanese encephalitis virus (JEV) and tick-
borne encephalitis virus (TBEV) are ﬂaviviruses responsible for
severe neuro-invasive infections in horses and humans. The
conﬁrmation of ﬂavivirus infections is mostly based on rapid
serological tests such as enzyme-linked immunosorbent assays
(ELISA). These tests suffer from poor speciﬁcity, mainly due to
antigenic cross-reactivity among ﬂavivirus members. Robust
diagnosis therefore needs to be validated through virus neutral-
isation tests (VNT) which are time-consuming and require BSL3
facilities. The ﬂavivirus envelope (E) glycoprotein ectodomain is
composed of three domains (D), e.g. DI, DII and DIII, with EDIII
containing virus-speciﬁc epitopes. In order to improve the sero-
logical differentiation of ﬂavivirus infections, the recombinant
soluble ectodomain of WNV E (WNV.sE) and EDIIIs (rEDIIIs) of
WNV, JEV and TBEV were synthesised using the Drosophila S2
expression system. Puriﬁed antigens were covalently bonded to
ﬂuorescent beads (ﬁgure 1). The microspheres coupled with
WNV.sE or rEDIIIs were assayed with about 300 equine immune
sera from natural and experimental ﬂavivirus infections and 172
non-immune equine sera as negative controls. rEDIII-coupled
microspheres captured speciﬁc antibodies against WNV, TBEV or
JEV in positive horse sera in a ﬂavivirus multiplex immunoassay
(MIA). MIA developed for the detection of ﬂavirus infection
showed a relative sensitivity and speciﬁcity close to 99% when
compared to ﬂavivirus competition ELISA. By comparison with
VNT, ﬂavivirus MIA correctly identiﬁed the causative ﬂavivirus in
100%, 96.8% and 90.0% WNV-, TBEV- and JEV-infected horses
respectively. Several advantages plead in favour of the develop-
ment and implementation of this ﬂavivirus MIA in reference
laboratories: no need for BSL3 facilities to conﬁrm ﬂavivirus in-
fections , requirement of small sampling volumes (1 ml) as well as
analysis speed-up (< 3hours).
Figure 1. Presentation of the ﬂavivirus MIA with four beads coupled to four
antigens (WNV.sE, WNV.EDIII, JEV.EDIII and TBEV.EDIII)
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VS is a zoonotic viral disease affecting livestock. The causa-
tive agent, Vesicular Stomatitis virus (VSV), belongs to the
genus Vesiculovirus in Rhabdoviridae family. Two serotypes
have been described: New Jersey (NJ) and Indiana (IND), the
latter being subdivided into 3 subtypes (Indiana 1, 2, 3). In
cattle and pigs, VS remains clinically difﬁcult to differentiate
from foot and mouth disease (FMD) when horses are not
involved. A prompt laboratory differential diagnosis is thus
essential. Serological diagnosis is based on VNT, Complement
Fixation and ELISA. This study describes the development of a
rapid serological diagnostic test based on Luminex technol-
ogy and its comparison with the VNT and Competitive ELISA
(C ELISA). The objective is to develop a multiplex Luminex
test allowing both serotyping and differential diagnosis of
VSV. The Luminex technology is based on the principle of
ﬂow cytometry and relies on the use of ﬂuorescent micro-
spheres (“beads”) which can be coupled to biological mac-
romolecules. A batch of beads was coupled to the envelope
glycoprotein of the VSV, serotype NJ (VSV-G-NJ), produced as
recombinant antigen using the baculovirus system and
harboring a C terminus tag MAT. The coupled beads were
incubated with positive equine sera and the antigen/antibody
complexes were revealed using biotinylated anti-species
antibody and streptavidin-phycoerythrin. Results were
analyzed on the Luminex200 platform. Median ﬂuorescence
intensity (MFI) values were measured and normalized. VNT
were conducted per the OIE manual for terrestrial animals,
using the alternative protocol (virus at 100 TCID50 /25mL).
Efﬁciency of antigen/bead coupling was assessed using a
monoclonal antibody speciﬁc to the MAT tag. Speciﬁcity of
the coupling was veriﬁed using a panel of well characterized
positive bovine VSV-NJ- or VSV-IND sera. The protocol was
then optimized for equine sera. A prototype test was thus
developed, with a cut off value determined using a panel of
100 naive horse sera, in two independent experiments. This
prototype was evaluated on a panel of positive equine sera.
VNT was performed on the same panel. Results obtained
show a good correlation between Luminex, VNT and C ELISA
analyses. A ﬁrst step in developing a Luminex-based sero-
logical test for VS diagnostic was reached, using the VSV-G
protein-NJ. Similar work is underway using a recombinant
VSV-G-IND protein and a duplex test is under development.
Bead sets coupled to these VSV-G proteins may also be
combined to bead batches developed in our laboratory for
FMD serological diagnosis with the aim to offer a differential
diagnostic VS/FMD in cattle. The sensitivity and speciﬁcity of
these luminex prototypes will also be compared to those
obtained with the VNT reference method.108
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